Business Context and Reporting Period
This Form 8-K is a current report filed by Exantas Capital Corp. (not ACRES Commercial Realty Corp. as indicated in the metadata) on February 24, 2020, covering events occurring on February 20, 2020. The registrant is a Maryland corporation with its principal executive offices in New York, NY. The filing primarily addresses the entry into a material definitive agreement regarding its management structure.
Key Financial Metrics
This filing is a current report regarding a contractual amendment and does not contain audited financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The text does not provide a clear value for any financial performance indicators.
Material Changes
The primary material change reported is the execution of an amendment to the Company's Third Amended and Restated Management Agreement dated December 14, 2017. The amendment involves the following:
- Entity Name Updates: Updated the names of the Company and the Manager (Exantas Capital Manager Inc.) to reflect recent corporate name changes.
- New Expense Reimbursement: Added a requirement for the Company to reimburse the Manager or its affiliates for expenses related to making fixed-rate commercial real estate loans. This reimbursement is set at 1% of the principal amount of each such loan.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on future outlook, or specific risk factors beyond the standard legal disclaimers associated with the amendment. The amendment introduces a new cost structure for the Company regarding fixed-rate commercial real estate loans, which may impact future operating expenses depending on loan origination volumes. A press release issued on February 24, 2020, is furnished as an exhibit but is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the full text of Exhibit 10.1 (Amendment No. 1) to understand the complete scope of the expense reimbursement clause.
- Confirm the impact of the 1% reimbursement fee on the Company's projected operating expenses relative to its loan origination pipeline.
- Review the press release attached as Exhibit 99.1 for any additional context on the name changes or strategic rationale.
- Note that this filing does not contain financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.